利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

123 条记录 (耗时 0.065 秒)

    Signal processing unit and wireless communication device
    51.
    发明授权
    Signal processing unit and wireless communication device 有权
    信号处理单元和无线通信设备

    公开(公告)号：US08233519B2

    公开(公告)日：2012-07-31

    申请号：US12382158

    申请日：2009-03-10

    申请人： Kaoru Kobayashi ,  Shigeru Takegishi

    发明人： Kaoru Kobayashi ,  Shigeru Takegishi

    IPC分类号： H04B1/00

    CPC分类号： H04L27/0014 ,  H04B1/70752 ,  H04L2027/0036 ,  H04L2027/0051 ,  H04L2027/0095

    摘要： A signal processing unit and a wireless communication device are provided for making it possible to detect a frequency by means of a small scale operation circuit in a short time. The signal processing unit and the wireless communication device are comprised of a carrier data generating unit; a carrier demodulation unit; a matched filter unit that divides carrier demodulated data into a plurality of portions, carries out despread processing and accumulating operation processing as partial correlation processing, further carries out full addition processing for the partial correlation processing result, and outputs correlation detected data; a correlation peak detecting unit that detects a correlation peak from the correlation detected data and outputs correlation peak position information; a coarse frequency deviation detecting unit that outputs a frequency deviation amount with respect to the carrier demodulated data to the carrier data generating unit; and a fine frequency deviation detecting unit that outputs a fine frequency deviation amount from the correlation detected data and the correlation peak position information to the carrier data generating unit.

    摘要翻译： 提供信号处理单元和无线通信装置，以便能够在短时间内利用小规模的操作电路来检测频率。 信号处理单元和无线通信设备包括载波数据生成单元; 载波解调单元; 将载波解调数据分割为多个部分的匹配滤波器单元，进行解扩处理并积累作为部分相关处理的运算处理，进一步执行部分相关处理结果的全相加处理，并输出相关检测数据; 相关峰值检测单元，根据相关检测数据检测相关峰值，并输出相关峰值位置信息; 粗频率偏差检测单元，向载波数据生成单元输出相对于载波解调数据的频率偏差量; 以及精细频率偏差检测单元，其将相关检测数据和相关峰值位置信息的精细频率偏差量输出到载波数据生成单元。

    Signal processing unit and wireless communication device
    52.
    发明授权
    Signal processing unit and wireless communication device 有权
    信号处理单元和无线通信设备

    公开(公告)号：US08204099B2

    公开(公告)日：2012-06-19

    申请号：US12382157

    申请日：2009-03-10

    申请人： Kaoru Kobayashi ,  Shigeru Takegishi

    发明人： Kaoru Kobayashi ,  Shigeru Takegishi

    IPC分类号： H04B1/69

    CPC分类号： H04B1/70752 ,  H04L27/0014 ,  H04L2027/0026 ,  H04L2027/0051 ,  H04L2027/0095

    摘要： A signal processing unit and a wireless communication device are comprised of a carrier data generating unit; a carrier demodulation unit; a matched filter unit that outputs correlation peak detected data; a correlation peak detecting unit that detects a correlation peak from the correlation detected data and outputs correlation peak position information; a coarse frequency deviation detecting unit that detects a frequency component in accordance with a carrier frequency deviation amount with respect to carrier demodulated data and outputs a frequency deviation amount to the carrier data generating unit; a fine frequency deviation detecting unit that outputs a fine frequency deviation amount to reduce the frequency deviation amount from the correlation detected data and the correlation peak position information to the carrier data generating unit; and a control unit that inputs the correlation peak position information and adjusts a processing clock signal.

    摘要翻译： 信号处理单元和无线通信设备由载波数据生成单元构成; 载波解调单元; 输出相关峰检测数据的匹配滤波器单元; 相关峰值检测单元，根据相关检测数据检测相关峰值，并输出相关峰值位置信息; 粗频率偏差检测单元，根据对载波解调数据的载波频率偏差量检测频率分量，并向载波数据生成单元输出频率偏差量; 精细频率偏差检测单元，其将相关检测数据和相关峰值位置信息的频率偏差量的精细频率偏差量输出到载波数据生成单元; 以及控制单元，其输入相关峰值位置信息并调整处理时钟信号。

    8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
    56.
    发明授权
    8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient 失效
    8-氮杂的前列腺素衍生物化合物和包含该化合物作为活性成分的试剂

    公开(公告)号：US07683094B2

    公开(公告)日：2010-03-23

    申请号：US12139260

    申请日：2008-06-13

    申请人： Kousuke Tani ,  Kaoru Kobayashi ,  Toru Maruyama ,  Tohru Kambe ,  Mikio Ogawa ,  Tsutomu Shiroya

    发明人： Kousuke Tani ,  Kaoru Kobayashi ,  Toru Maruyama ,  Tohru Kambe ,  Mikio Ogawa ,  Tsutomu Shiroya

    IPC分类号： A61K31/40 ,  C07D207/00

    CPC分类号： C07D413/06 ,  C07D207/26 ,  C07D263/24 ,  C07D405/06 ,  C07D405/12 ,  C07D409/06 ,  C07D409/12 ,  C07D413/12 ,  C07D417/06 ,  C07D417/12

    摘要： An 8-azaprostaglandin represented by formula (I) (wherein all symbols have the same meanings as described in the specification), a pharmaceutically acceptable salt thereof or a cyclodextrin clathrate thereof. Since the compound represented by formula (I) binds to EP2 subtype among PGE receptor strongly, it is useful for preventive and/or treatment for immune diseases, allergic diseases, neuronal cell death, dysmenorrhea, premature birth, abortion, baldness, retinal neuropathy such as glaucoma, erectile dysfunction, arthritis, pulmonary injury, pulmonary fibrosis, pulmonary emphysema, bronchitis, chronic obstructive pulmonary disease, hepatic injury, acute hepatitis, liver cirrhosis, shock, nephritis, renal failure, circulatory diseases, systemic inflammatory response syndrome, sepsis, hemophagocytosis syndrome, macrophage activation syndrome, still disease, Kawasaki Disease, burn, systemic granuloma, ulcerative colitis, Crohn disease, hypercytokinemia at dialysis, multiple organ failure, or bone diseases etc.

    摘要翻译： 由式（I）（其中所有符号具有与说明书中所述相同的含义）表示的8-氮杂前列腺素，其药学上可接受的盐或其环糊精包合物。 由于式（I）表示的化合物强烈地与PGE受体中的EP2亚型结合，因此可用于免疫疾病，过敏性疾病，神经元细胞死亡，痛经，早产，流产，秃发，视网膜神经病变等的预防和/或治疗 青光眼，勃起功能障碍，关节炎，肺损伤，肺纤维化，肺气肿，支气管炎，慢性阻塞性肺病，肝损伤，急性肝炎，肝硬化，休克，肾炎，肾衰竭，循环系统疾病，全身性炎症反应综合征，败血症， 血细胞增多综合征，巨噬细胞活化综合征，静止病，川崎病，烧伤，全身肉芽肿，溃疡性结肠炎，克罗恩病，透析中的高细胞因子血症，多器官功能衰竭或骨骼疾病等。

    CARBOXYLIC ACID COMPOUNDS AND MEDICINAL COMPOSITIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
    57.
    发明申请
    CARBOXYLIC ACID COMPOUNDS AND MEDICINAL COMPOSITIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT 有权
    羧酸化合物和含有相同活性成分的药物组合物

    公开(公告)号：US20100029631A1

    公开(公告)日：2010-02-04

    申请号：US12551860

    申请日：2009-09-01

    申请人： Atsushi Naganawa ,  Maki Iwahashi ,  Atsushi Kinoshita ,  Atsushi Shimabukuro ,  Seiji Ogawa ,  Koji Yano ,  Kaoru Kobayashi ,  Yutaka Okada ,  Yoko Kishida ,  Shouji Kawauchi ,  Kohki Tsukamoto ,  Yoko Matsunaga ,  Fumio Nambu

    发明人： Atsushi Naganawa ,  Maki Iwahashi ,  Atsushi Kinoshita ,  Atsushi Shimabukuro ,  Seiji Ogawa ,  Koji Yano ,  Kaoru Kobayashi ,  Yutaka Okada ,  Yoko Kishida ,  Shouji Kawauchi ,  Kohki Tsukamoto ,  Yoko Matsunaga ,  Fumio Nambu

    IPC分类号： A61K31/538 ,  C07D265/36 ,  A61P37/08 ,  A61P11/06

    CPC分类号： C07D307/80 ,  A61K31/343 ,  A61K31/538 ,  C07D265/36 ,  C07D317/48

    摘要： A compound represented by formula (I) wherein the symbols in the formula are the same meanings as those in specification, salts thereof, solvates thereof, or prodrugs thereof binds to DP receptor and shows antagonistic activity for DP receptor. Thus, it is useful for prevention and/or treatment of diseases such as allergic disease (e.g., allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic mastocytosis, disorders accompanied by systemic mast cell activation, anaphylaxis shock, bronchoconstriction, urticaria, eczema, diseases accompanied by itch (e.g., atopic dermatitis and urticaria), diseases (e.g., cataract, retinal detachment, inflammation, infection and sleeping disorders) which is generated secondarily as a result of behavior accompanied by itch (e.g., scratching and beating), inflammation, chronic obstructive pulmonary diseases, ischemic reperfusion injury, cerebrovascular accident, chronic rheumatoid arthritis, pleurisy, ulcerative colitis, etc. Since it specifically binds to DP receptor and binds weakly to other prostaglandins receptors, they can be pharmaceuticals having little side effect.

    摘要翻译： 由式（I）表示的化合物，其中式中的符号与说明书中的符号相同，其盐，溶剂合物或其前药与DP受体结合并显示DP受体的拮抗活性。 因此，它可用于预防和/或治疗过敏性疾病（例如过敏性鼻炎，过敏性结膜炎，特应性皮炎，支气管哮喘和食物过敏），系统性肥大细胞增多症，伴有全身性肥大细胞活化的病症，过敏性休克， 支气管收缩，荨麻疹，湿疹，伴有瘙痒的疾病（例如特应性皮炎和荨麻疹），伴随瘙痒的行为的结果产生的疾病（例如白内障，视网膜脱离，炎症，感染和睡眠障碍）（例如， 搔抓和殴打），炎症，慢性阻塞性肺疾病，缺血再灌注损伤，脑血管意外，慢性类风湿关节炎，胸膜炎，溃疡性结肠炎等。由于其特异性结合DP受体并且弱结合到其他前列腺素受体，它们可以是具有 小副作用。